Germany based Gerresheimer AG, one of the world’s leading suppliers of high quality speciality glass and plastic products to the pharma and healthcare industry, has set up a representative office in Mumbai reflecting the company’s commitment to the strategy of profiting from the consistent growth in emerging markets. Gerresheimer intends to advance its very promising pharmaceutical primary packaging and drug delivery systems business in the growing market of India. In addition to sales operations, the company is also stepping up its local customer services and technical services.

“Our strategic objective is to achieve above average growth in the emerging markets. We currently generate around ten per cent of our revenues in these dynamically growing markets and we aim to double this figure over the next three years. Opening our representative office in India is an important step towards achieving this objective,” informed Uwe Röhrhoff, CEO, Gerresheimer AG.

Alongside China, where Gerresheimer already has seven production facilities, the fast-growing Indian pharma market is continually gaining in significance. There is incessant growth of demand for medicines in India. One reason for this is the improvement of the Indian healthcare system, which gives people greater access to medications. International pharmaceutical groups are now also manufacturing more products in India for other regions. Leading market research institutes expect above average growth rates in emerging nation pharma markets over coming  years, he said.

Gerresheimer is a leading manufacturer of high quality speciality glass and plastic products for the international pharmaceuticals and healthcare industries. Their comprehensive portfolio of products extends from pharmaceutical vials to complex drug delivery systems such as syringe systems, insulin pens and inhalers for safe medication dosage and application. The Group has production operations at 40 sites in Europe, North and South America and Asia.